As cells undergoing EMT acquire features of cancer stem cells51 and given the fact that KIAA1199 critically promotes EMT, we next assessed whether KIAA1199 deficiency impaired the pool of cancer stem cells, defined as CD44+/CD24− cells. The gene discussed is CEMIP; the disease is cancer.